Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 89,659	$ 126,590
Marketable securities, current	168,533	127,091
Accounts receivable	13,599	11,799
Prepaid expenses and other current assets	7,801	5,709
Total current assets	279,592	271,189
Marketable securities, non-current	40,975	28,008
Property and equipment, net	6,756	7,132
Right-of-use asset	62,377	63,956
Restricted cash	3,443	3,443
Other assets	5,228	2,723
Total assets	398,371	376,451
Current liabilities:
Accounts payable	1,630	1,446
Accrued expenses and other current liabilities	12,891	20,630
Deferred revenue, current	35,142	15,471
Operating lease liability, current	5,355	5,219
Total current liabilities	55,018	42,766
Deferred revenue, net of current	20,706	21,814
Operating lease liability, net of current	64,365	65,757
Total liabilities	140,089	130,337
Commitments and contingencies (see Note 11)
Stockholders’ equity:
Preferred stock, par value of $0.0001 per share; 10,000,000 shares authorized, and no shares issued or outstanding as of March 31, 2024 and December 31, 2023, respectively	0	0
Common stock, par value of $0.0001 per share; 150,000,000 shares authorized, and 68,778,591 and 60,467,188 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	7	6
Additional paid-in capital	815,399	774,618
Accumulated other comprehensive loss	(380)	(127)
Accumulated deficit	(556,744)	(528,383)
Total stockholders’ equity	258,282	246,114
Total liabilities and stockholders’ equity	$ 398,371	$ 376,451